How the DA subtype of Wilms tumour resists chemotherapy
Researchers suggest that DA histology slowly emerges by accumulating burdens of DNA damage and copy number aberrations.
List view / Grid view
Researchers suggest that DA histology slowly emerges by accumulating burdens of DNA damage and copy number aberrations.
A deep learning model developed using circulating cell-free DNA outperformed traditional screening methods for gestational diabetes mellitus.
Regenerating bladder tissue with bone marrow stem and progenitor cells gives hope to patients with end-stage bladder dysfunction.
A new study has identified targets to refine diagnostic tests, track disease progression, and discover more effective therapies.
The interactions linking intestinal microbiota with the functionality of basally resident alveolar macrophages and severity of infection are revealed.
The new study suggests that this gene therapy method may combat ARVC in both early and more advanced stages of the condition.
A novel technology can reduce tumour sizes significantly and improve treatment efficacy when used with existing immunotherapy.
A new project plans to elucidate the relationship between the glucosylceramidase beta gene and Parkinson’s disease.
For the first time, mitochondrial DNA mutations could be used with immunotherapy to increase the chances of successful treatments.
A new learning-based framework enables patients and caregivers to predict the timing of any of the five clinical groups of AD development.
The Ku70 protein prevents cancer cells from becoming more aggressive and metastasising. It could also be used as an immune biomarker.
Low dose ionising radiation reduced lesion size and reversed motor deficits in traumatic brain injury and ischemic stroke mice.
Using CRISPRa to activate genes in readily accessible cells provides an effective and accurate diagnosis of genetic diseases.
The discovery that HIV capsids are importin-like transporters could be exploited for improved AIDS therapies.
Researchers observed significant upregulation of Siglec-15 in the tumour microenvironment in bone tumour samples from breast cancer patients.